Register entry

MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
4
Labeller names
3
Live patents
6
Countries
0
Catalogue

Drug listings by form and route

4

4 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.

Dosage formNDCs
tablet, film coated2
injection1
injection, solution1
RouteNDCs
oral2
subcutaneous2
Labeller name on the listingNDCs
mdd us operations llc, a subsidiary of supernus pharmaceuticals, inc.2
mdd us operations, llc1
mdd us operations, llc, a subsidiary of supernus pharmaceuticals, inc1
Exclusivity

Patents and exclusivities

6
PatentProductCoversExpiry
8278485XADAGOsafinamide mesylatesubstanceJun 2027
8076515XADAGOsafinamide mesylatesubstance, productDec 2028
8283380XADAGOsafinamide mesylateuseMar 2031
Catalogue

Marketed products

4
BrandGeneric nameForm / routeNDC
APOKYNAPOMORPHINE HYDROCHLORIDEinjection, subcutaneous27505-004NDA
ONAPGOApomorphine hydrochlorideinjection, solution, subcutaneous27505-006NDA
Xadagosafinamide mesylatetablet, film coated, oral27505-110NDA
Xadagosafinamide mesylatetablet, film coated, oral27505-111NDA
Enquiry

Common questions

Is MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. FDA approved?
MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. make?
4 products are listed under MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, film coated; injection; injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.